In 2011, Dr. Charles Runels, M.D. pioneered an ingenious application of PRP (Platelet Rich Plasma) therapy called the O-Shot. Today, the O-Shot is poised to do for women what Viagra has done for men since 1994. Actually, the O-Shot is even better than Viagra — there are no pills to take, very minimal side effects (minor spotting for the first 12 hours after the injections), and the results lasts up to one year.
The O-Shot is a series of PRP injections in the anterior wall (roof) of the vagina and in and around the clitoris. (A local anesthetic cream completely numbs the entire vaginal area.)
The O-Shot regenerates vaginal tissue and rejuvenates the female sexual response.
Although the results of recent clinical studies about the O-Shot will not be published until mid-2014, the anecdotal results from Dr. Runels and hundreds of other physicians around the country confirm the following benefits from the O-Shot:
- Increased sexual arousal and desire
- Improved natural vaginal lubrication
- Reawakened feelings of bonding during sex
- More frequent orgasms
- Stronger orgasms
- Virtually eliminates stress incontinence (in more then 90% of cases)
- Decreased pain during intercourse (if any was present before)
- Minimal, if any, side effects (minor spotting for the first 12 hours)
- Takes one-three weeks to see results; full effects achieved within three months
- Effects last may last one year or longer
How the O-Shot Works
As with all PRP procedures, the O-Shot begins with a couple of vials of blood being drawn. The plasma that contains the PRP is then separated from the red and white blood cells by a centrifuge. The platelets, which contain highly active glycoproteins known as growth factors (also called “chemokines” and “cytokines”), are then injected with an extremely thin needle (27 gauge) into the anesthetized areas mentioned above.
The chemokines and cytokines within the PRP stimulate the local “uni-potent” stem cells (stem cells that only produce new cells in the adjacent tissue), which in turn initiates the production of new tissue in and around the injection locations. The growth factors within PRP stimulate the productions of new cells, enhance the migration of these cells in and around the injection sites, repair damaged cells, and extend the life of existing cells — all of which contribute to tissue rejuvenation.
PRP injections also enhance the proliferation of fibroblast growth factors (FGF) that direct the formation of new blood vessels and capillaries (angiogenesis) and wound healing.
As with wound healing, the rejuvenation of the roof of the vagina and the clitoris involves numerous tissue types (blood vessels, nerves, smooth muscle fibers, lymph vessels, connective tissues, endothelium and so on). So when the vagina and the clitoris receive a concentrated wave of bioactive glycoproteins and FGF from a PRP injection, they immediately begin the process of generating new tissue.
“It is this new tissue in and around the clitoris that stimulates a “more amorous” sexual response, while the natural build up of tissue in the roof of the vagina virtually eliminates stress incontinence. It is this rejuvenated tissue that is responsible for the female sexual response,” Dr. Kevin Aister, M.D. of Scottsdale, Arizona told Fox News in January 2013.
For additional information about the O-Shot, please contact the HOPE Protocol at 303-554-4444 — and be sure to look for an article about Dr. Runels and the O-Shot in the February 2014 edition Harper’s Magazine.